Page last updated: 2024-09-04

moxifloxacin and 14-hydroxyclarithromycin

moxifloxacin has been researched along with 14-hydroxyclarithromycin in 1 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (14-hydroxyclarithromycin)	Trials (14-hydroxyclarithromycin)	Recent Studies (post-2010) (14-hydroxyclarithromycin)
3,157	552	1,690	59	14	5

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allewelt, M; Beyer, G; Borner, K; Burkhardt, O; Lode, H; Nord, CE; Stass, H	1

Trials

1 trial(s) available for moxifloxacin and 14-hydroxyclarithromycin

Article	Year
Single- and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faeces. Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:12 Topics: Administration, Oral; Adult; Anti-Infective Agents; Aza Compounds; Clarithromycin; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Feces; Fluoroquinolones; Half-Life; Humans; Intestines; Male; Metabolic Clearance Rate; Moxifloxacin; Oropharynx; Quinolines; Saliva	2002

Article

Year

Single- and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faeces.

Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:12

Topics: Administration, Oral; Adult; Anti-Infective Agents; Aza Compounds; Clarithromycin; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Feces; Fluoroquinolones; Half-Life; Humans; Intestines; Male; Metabolic Clearance Rate; Moxifloxacin; Oropharynx; Quinolines; Saliva

2002